FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the chemical and pharmaceutical industry and is stable long-acting human growth hormone conjugate compositions, which is a lyophilized long-acting human growth hormone conjugate composition, comprising a lyophilized mixture of an aqueous solution comprising a long-term human growth hormone conjugate, in which human growth hormone is linked to an immunoglobulin Fc fragment, and an albumin-free solution comprising a buffer solution, nonionic surfactant, sugar alcohol, and sodium chloride as an isotonic agent; as well as a human long-term growth hormone conjugate liquid composition comprising a pharmaceutically effective amount of the human long-term growth hormone conjugate in which a human growth hormone is linked to an immunoglobulin Fc fragment, and an albumin-free stabilizer, wherein the stabilizer comprises a buffer solution, a nonionic surfactant and a sugar alcohol, wherein the composition does not comprise a water-soluble inorganic salt. Invention also provides a method for producing a lyophilized composition, comprising lyophilization of the human long-term growth hormone conjugate, and a method for reconstituting said lyophilized composition, comprising adding a reconstituting solution to the lyophilized mixture of an aqueous solution comprising a human long-term growth hormone conjugate. Inventions include a kit for producing a stable composition comprising said lyophilized composition and water for injection as a reconstituting solution.
EFFECT: group of inventions ensures the stability of the composition capable of maintaining the stability of a human long-term growth hormone conjugate during the lyophilization and after reconstituting the composition for a long period of time, even when it comprises a preservative.
35 cl, 23 tbl, 4 dwg, 40 ex
Title | Year | Author | Number |
---|---|---|---|
LIQUID COMPOSITION OF HUMAN GROWTH HORMONE WITH PROLONGED ACTION | 2011 |
|
RU2623026C2 |
LIQUID FORMULATION OF LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2013 |
|
RU2671576C2 |
LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE | 2013 |
|
RU2670270C2 |
LIQUID FORMULATIONS FOR LONG-ACTING ERYTHROPOIETIN CONJUGATE | 2011 |
|
RU2682720C2 |
LIQUID COMPOSITION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE | 2013 |
|
RU2643766C2 |
PROTEIN COMPLEX, OBTAINED BY USING FRAGMENT OF IMMUNOGLOBULIN, AND METHOD OF SUCH COMPLEX OBTAINING | 2004 |
|
RU2356909C2 |
LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE | 2011 |
|
RU2613905C2 |
LIQUID FORMULATIONS FOR LONG-ACTING CONJUGATE OF G-CSF | 2011 |
|
RU2519031C1 |
PHARMACEUTICAL COMPOSITION CONTAINING Fc-REGION OF IMMUNOGLOBULIN AS CARRIER | 2004 |
|
RU2352583C2 |
NEW METHOD FOR OBTAINING LONG-ACTING DRUG CONJUGATE BY PRODUCING INTERMEDIATE | 2019 |
|
RU2805873C2 |
Authors
Dates
2019-04-02—Published
2014-09-26—Filed